Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125631202 | 12563120 | 2 | F | 20000322 | 20160715 | 20160715 | 20160726 | EXP | JP-009507513-01062443 | MERCK | 42.00 | YR | M | Y | 0.00000 | 20160726 | CN | US | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125631202 | 12563120 | 1 | SS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 200 MG, TID | N | 0 | 200 | MG | CAPSULE | TID | |||||
125631202 | 12563120 | 2 | PS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 800 MG, QD | 22145 | 800 | MG | TABLET | QD | ||||||
125631202 | 12563120 | 3 | SS | NORVIR | RITONAVIR | 1 | Oral | 600 MG, BID | 467400 | MG | N | 0 | 600 | MG | ORAL SOLUTION | BID | |||
125631202 | 12563120 | 4 | SS | NORVIR | RITONAVIR | 1 | Oral | 300 MG, BID | 467400 | MG | N | 0 | 300 | MG | ORAL SOLUTION | BID | |||
125631202 | 12563120 | 5 | SS | NORVIR | RITONAVIR | 1 | Oral | 600 MG, QD | 467400 | MG | N | 0 | 600 | MG | ORAL SOLUTION | QD | |||
125631202 | 12563120 | 6 | SS | NORVIR | RITONAVIR | 1 | Oral | 200 MG, QD | 467400 | MG | N | 0 | 200 | MG | ORAL SOLUTION | QD | |||
125631202 | 12563120 | 7 | SS | NORVIR | RITONAVIR | 1 | Oral | 200 MG, QD | 467400 | MG | N | 0 | 200 | MG | ORAL SOLUTION | QD | |||
125631202 | 12563120 | 8 | SS | ZERIT | STAVUDINE | 1 | Oral | 30 MG, BID | 41640 | MG | N | U | 0 | 30 | MG | CAPSULE | BID | ||
125631202 | 12563120 | 9 | SS | ZERIT | STAVUDINE | 1 | Oral | 80 MG, QD | 41640 | MG | N | U | 0 | 80 | MG | CAPSULE | QD | ||
125631202 | 12563120 | 10 | SS | VIDEX | DIDANOSINE | 1 | Oral | 100 MG, BID | 65600 | MG | N | 0 | 100 | MG | TABLET | BID | |||
125631202 | 12563120 | 11 | SS | VIDEX | DIDANOSINE | 1 | Oral | 200 MG, BID | 65600 | MG | N | 0 | 200 | MG | TABLET | BID | |||
125631202 | 12563120 | 12 | SS | VIDEX | DIDANOSINE | 1 | Oral | 100 MG, BID | 65600 | MG | N | 0 | 100 | MG | TABLET | BID | |||
125631202 | 12563120 | 13 | SS | VIDEX | DIDANOSINE | 1 | Oral | 250 MG, UNKNOWN | 65600 | MG | N | 0 | 250 | MG | TABLET | ||||
125631202 | 12563120 | 14 | SS | VIDEX | DIDANOSINE | 1 | Oral | 300 MG, QD | 65600 | MG | N | 0 | 300 | MG | TABLET | QD | |||
125631202 | 12563120 | 15 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 8 TABLETS DAILY | N | U | 0 | 8 | DF | CAPSULE | QD | ||||
125631202 | 12563120 | 16 | SS | PROZEI | AMPRENAVIR | 1 | Oral | 1500MG, QD | N | U | 0 | CAPSULE | QD | ||||||
125631202 | 12563120 | 17 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DOSAGE FORM, DIVIDED DOSE FREQUENCY UNKNOWN | U | 0 | 1 | DF | TABLET | ||||||
125631202 | 12563120 | 18 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | 600 MG, BID | U | 0 | 600 | MG | TABLET | BID | |||||
125631202 | 12563120 | 19 | SS | INTELENCE | ETRAVIRINE | 1 | Oral | 200 MG, BID | U | 0 | 200 | MG | TABLET | BID | |||||
125631202 | 12563120 | 20 | C | ZIAGEN | ABACAVIR SULFATE | 1 | Oral | 300 MG, BID | U | 0 | 300 | MG | TABLET | BID | |||||
125631202 | 12563120 | 21 | C | INVIRASE | SAQUINAVIR MESYLATE | 1 | Oral | 400 MG, BID | 173252.1 | MG | U | 0 | 400 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125631202 | 12563120 | 1 | HIV infection |
125631202 | 12563120 | 2 | HIV infection |
125631202 | 12563120 | 3 | HIV infection |
125631202 | 12563120 | 8 | HIV infection |
125631202 | 12563120 | 10 | HIV infection |
125631202 | 12563120 | 15 | HIV infection |
125631202 | 12563120 | 16 | HIV infection |
125631202 | 12563120 | 17 | HIV infection |
125631202 | 12563120 | 18 | HIV infection |
125631202 | 12563120 | 19 | HIV infection |
125631202 | 12563120 | 20 | HIV infection |
125631202 | 12563120 | 21 | HIV infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125631202 | 12563120 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125631202 | 12563120 | Hepatic cirrhosis | |
125631202 | 12563120 | Hypertriglyceridaemia | |
125631202 | 12563120 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125631202 | 12563120 | 1 | 19990819 | 20040331 | 0 | |
125631202 | 12563120 | 2 | 20070807 | 0 | ||
125631202 | 12563120 | 3 | 19961218 | 19970924 | 0 | |
125631202 | 12563120 | 4 | 19990819 | 20000331 | 0 | |
125631202 | 12563120 | 5 | 20000401 | 20001228 | 0 | |
125631202 | 12563120 | 6 | 20060411 | 20110608 | 0 | |
125631202 | 12563120 | 7 | 20110608 | 0 | ||
125631202 | 12563120 | 8 | 19970924 | 19990818 | 0 | |
125631202 | 12563120 | 9 | 20001229 | 20060410 | 0 | |
125631202 | 12563120 | 10 | 19951018 | 19951206 | 0 | |
125631202 | 12563120 | 11 | 19951207 | 19960313 | 0 | |
125631202 | 12563120 | 12 | 19960314 | 19960723 | 0 | |
125631202 | 12563120 | 13 | 19960724 | 19970924 | 0 | |
125631202 | 12563120 | 14 | 20001229 | 20060410 | 0 | |
125631202 | 12563120 | 15 | 20001229 | 20060410 | 0 | |
125631202 | 12563120 | 16 | 20040401 | 20051110 | 0 | |
125631202 | 12563120 | 17 | 20060411 | 0 | ||
125631202 | 12563120 | 18 | 20061011 | 0 | ||
125631202 | 12563120 | 19 | 20081011 | 0 | ||
125631202 | 12563120 | 20 | 19990819 | 20001228 | 0 | |
125631202 | 12563120 | 21 | 19990819 | 20001229 | 0 |